A detailed history of Us Bancorp \De\ transactions in Royalty Pharma PLC stock. As of the latest transaction made, Us Bancorp \De\ holds 3,806 shares of RPRX stock, worth $97,814. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,806
Previous 5,856 35.01%
Holding current value
$97,814
Previous $154,000 30.52%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

SELL
$25.63 - $29.27 $52,541 - $60,003
-2,050 Reduced 35.01%
3,806 $107,000
Q2 2024

Aug 06, 2024

SELL
$26.26 - $29.9 $92,619 - $105,457
-3,527 Reduced 37.59%
5,856 $154,000
Q1 2024

May 07, 2024

BUY
$27.46 - $31.33 $23,725 - $27,069
864 Added 10.14%
9,383 $284,000
Q4 2023

Feb 09, 2024

BUY
$26.21 - $29.22 $124,733 - $139,057
4,759 Added 126.57%
8,519 $239,000
Q3 2023

Nov 03, 2023

BUY
$26.26 - $31.38 $38,575 - $46,097
1,469 Added 64.12%
3,760 $102,000
Q2 2023

Aug 09, 2023

SELL
$29.6 - $36.56 $96,140 - $118,746
-3,248 Reduced 58.64%
2,291 $70,000
Q1 2023

May 09, 2023

BUY
$32.77 - $39.4 $38,799 - $46,649
1,184 Added 27.19%
5,539 $199,000
Q4 2022

Feb 13, 2023

SELL
$39.17 - $44.04 $24,520 - $27,569
-626 Reduced 12.57%
4,355 $172,000
Q3 2022

Oct 27, 2022

SELL
$39.88 - $44.65 $274,733 - $307,593
-6,889 Reduced 58.04%
4,981 $201,000
Q2 2022

Aug 01, 2022

BUY
$37.53 - $44.22 $28,710 - $33,828
765 Added 6.89%
11,870 $499,000
Q1 2022

May 11, 2022

BUY
$37.46 - $42.44 $135,155 - $153,123
3,608 Added 48.13%
11,105 $433,000
Q4 2021

Feb 11, 2022

BUY
$35.17 - $42.48 $263,669 - $318,472
7,497 New
7,497 $299,000
Q3 2021

Nov 10, 2021

SELL
$36.14 - $42.24 $33,537 - $39,198
-928 Closed
0 $0
Q2 2021

Aug 05, 2021

BUY
$39.85 - $46.63 $916 - $1,072
23 Added 2.54%
928 $38,000
Q2 2020

Aug 07, 2020

BUY
$44.5 - $52.11 $40,272 - $47,159
905 New
905 $44,000

Others Institutions Holding RPRX

About Royalty Pharma plc


  • Ticker RPRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 437,139,008
  • Market Cap $11.2B
  • Description
  • Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...
More about RPRX
Track This Portfolio

Track Us Bancorp \De\ Portfolio

Follow Us Bancorp \De\ and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Us Bancorp \De\, based on Form 13F filings with the SEC.

News

Stay updated on Us Bancorp \De\ with notifications on news.